Today: 20 May 2026
Browse Category

NYSE:NEXT 18 January 2026

Venture Global stock price jumps 11% into MLK holiday week as LNG prices firm — what to watch next

Venture Global stock price jumps 11% into MLK holiday week as LNG prices firm — what to watch next

Venture Global shares surged 10.6% to $8.80 Friday, with trading volume reaching 15.4 million. The company cut its 2025 profit forecast to $6.18–$6.24 billion amid volatile LNG prices and shipping bottlenecks. Spot LNG prices in Asia hit a six-week high as colder weather forecasts boosted demand. Venture Global faces ongoing investor scrutiny and arbitration cases over past delays.
18 January 2026
····

Stock Market Today

  • Stellantis CEO Filosa to Unveil Turnaround Plan Amid Nearly 30% Stock Decline
    May 20, 2026, 7:51 AM EDT. Stellantis CEO Antonio Filosa, nearly a year into his tenure, faces a nearly 30% drop in the automaker's stock. On Thursday, Filosa and his executive team will present a detailed turnaround strategy at a capital markets day near Detroit. The plan aims to prioritize key regional brands like Jeep, Ram, Fiat, and Peugeot, focusing on cost reduction and a return to profitability after a €22.3 billion net loss last year. Filosa promises clear targets and a focused execution roadmap. Industry challenges include AI impact, Chinese competition, U.S. tariffs, and Stellantis' retreat from previous electric vehicle ambitions. Investors await clarity on 2026 guidance amid ongoing restructuring efforts.

Latest articles

CleanSpark Stock Jumps as Wall Street Chases the AI Power Trade

CleanSpark Stock Jumps as Wall Street Chases the AI Power Trade

20 May 2026
CleanSpark shares rose 1.7% to $14.94 in pre-market trading Wednesday after Bernstein rated the stock Outperform with a $24 target, citing the value of miners’ power capacity for AI data centers. CleanSpark holds 1.8 gigawatts under contract and produced 640 bitcoin in April. The company reported fiscal Q2 revenue of $136.4 million, down 24.9% year-over-year, and a net loss of $378.3 million.
Silexion’s Cancer Trial Push Puts Focus on Cash

Silexion’s Cancer Trial Push Puts Focus on Cash

20 May 2026
Silexion reported Israeli clearance and a German filing for its SIL204 pancreatic cancer drug, keeping its Phase 2/3 trial on track for a second-quarter start. The company posted a first-quarter net loss of $2.7 million and held $2.4 million in cash at March 31. Shares closed at 26.9 cents Tuesday after a sharp drop last week. Management warned of “substantial doubt” about ongoing operations without new funding.
CAVA Jumps in Pre-Market After New Traffic Data Update

CAVA Jumps in Pre-Market After New Traffic Data Update

20 May 2026
Cava Group shares rose 6.9% in premarket trading Wednesday after the chain reported a 9.7% jump in same-restaurant sales and beat first-quarter earnings and revenue estimates. Net income fell to $23.6 million from $25.7 million a year earlier. The company opened 20 net new restaurants and raised its 2026 outlook for openings and sales growth. Several analysts raised their price targets following the results.
Go toTop